retatrutide type 2 diabetes trial results 28.7% Weight Loss in New Study – Dr Brad Stanfield How Does Retatrutide Work? Doctor

This dual agonist approach enhances its potential for glycemic control and weight loss in patients with type 2 diabetes

Physical activity amplifies retatrutide results by preserving muscle mass during weight loss (critical for maintaining metabolic rate), increasing the caloric deficit beyond what appetite suppression alone achieves, and improving insulin sensitivity, which supports the metabolic effects of the medication

Some of the most well-known GLP-1 medications include: Liraglutide (Saxenda, Victoza) Semaglutide (Ozempic, Wegovy, Rybelsus) Dulaglutide (Trulicity) Tirzepatide (Mounjaro) also a GIP agonist These medications have shown remarkable success in clinical trials and real-world use for both glycemic control and weight loss

Mike Haney: So is it in a way sort of then creating a new settling point if we like that sort of term for where your body wants to be

doi: 10.1056/NEJMoa2505669

The same studies can be located independently on PubMed using the CAS number (2381089-83-2) or the compound name